Gaois

Search direction

Search mode

Filter results

Collections

25 results in 22 documents

  1. #346889

    An Buanchoiste um Tháirgí Íocshláinte Tréidliachta

    Standing Committee on Veterinary Medicinal Products

    Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council

  2. #346890

    Tabharfaidh an Buanchoiste um Tháirgí Íocshláinte Tréidliachta cúnamh don Choimisiún.

    The Commission shall be assisted by the Standing Committee on Veterinary Medicinal Products.

    Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council

  3. #1735334

    Buanchoiste um Tháirgí Íocshláinte Tréidliachta

    Standing Committee on Veterinary Medicinal Products

    Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)

  4. #1735335

    Déanfaidh an Buanchoiste um Tháirgí Íocshláinte Tréidliachta (“an Buanchoiste”) cúnamh a thabhairt don Choimisiún.

    The Commission shall be assisted by the Standing Committee on Veterinary Medicinal Products (‘the Standing Committee’).

    Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)

  5. #1911353

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta dá dtagraítear in Airteagal 145 de Rialachán (AE) 2019/6,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products referred to in Article 145 of Regulation (EU) 2019/6,

    Commission Implementing Regulation (EU) 2021/16 of 8 January 2021 laying down the necessary measures and practical arrangements for the Union database on veterinary medicinal products (Union product database)

  6. #1911770

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir le tuairim an Bhuanchoiste um Táirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2021/17 of 8 January 2021 establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

  7. #2021774

    Na bearta dá bhforáiltear sa Rialachán seo, tá siad i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2021/621 of 15 April 2021 amending Regulation (EU) No 37/2010 to classify the substance imidacloprid as regards its maximum residue limit in foodstuffs of animal origin (Text with EEA relevance)

  8. #2113320

    Is i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta dá dtagraítear in Airteagal 145 de Rialachán (AE) 2019/6 atá na bearta dá bhforáiltear sa Rialachán seo,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products referred to in Article 145 of Regulation (EU) 2019/6,

    Commission Implementing Regulation (EU) 2021/1248 of 29 July 2021 as regards measures on good distribution practice for veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

  9. #2116061

    Is i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta dá dtagraítear in Airteagal 145 de Rialachán (AE) 2019/6 atá na bearta dá bhforáiltear sa Rialachán seo,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products referred to in Article 145 of Regulation (EU) 2019/6,

    Commission Implementing Regulation (EU) 2021/1280 of 2 August 2021 as regards measures on good distribution practice for active substances used as starting materials in veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

  10. #2116371

    Na bearta dá bhforáiltear sa Chinneadh seo, tá siad i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2021/1281 of 2 August 2021 laying down rules for the application of Regulation (EU) 2019/6 of the European Parliament and of the Council as regards good pharmacovigilance practice and on the format, content and summary of the pharmacovigilance system master file for veterinary medicinal products (Text with EEA relevance)

  11. #2147576

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2021/1904 of 29 October 2021 adopting the design of a common logo for the retail of veterinary medicinal products at a distance (Text with EEA relevance)

  12. #2304235

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta dá dtagraítear in Airteagal 145 de Rialachán (AE) 2019/6,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products referred to in Article 145 of Regulation (EU) 2019/6,

    Commission Implementing Regulation (EU) 2022/209 of 16 February 2022 establishing the format of the data to be collected and reported in order to determine the volume of sales and the use of antimicrobial medicinal products in animals in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

  13. #2352892

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2022/634 of 13 April 2022 amending Regulation (EU) No 37/2010 as regards the classification of the substance bambermycin with respect to its maximum residue limit in foodstuffs of animal origin (Text with EEA relevance)

  14. #2480849

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta dá dtagraítear in Airteagal 145 de Rialachán (AE) 2019/6,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products referred to in Article 145 of Regulation (EU) 2019/6,

    Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

  15. #2818151

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2023/981 of 17 May 2023 amending Regulation (EU) No 37/2010 as regards the classification of the substance praziquantel with respect to its maximum residue limit in foodstuffs of animal origin (Text with EEA relevance)

  16. #2825775

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Táirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2023/997 of 23 May 2023 amending Implementing Regulation (EU) 2021/17 establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

  17. #3006757

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Táirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2023/2194 of 19 October 2023 amending Regulation (EU) No 37/2010 as regards the classification of the substance ketoprofen with respect to its maximum residue limit in foodstuffs of animal origin

  18. #3007746

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2023/2203 of 20 October 2023 amending Regulation (EU) No 37/2010 as regards the classification of the substance rafoxanide with respect to its maximum residue limit in foodstuffs of animal origin

  19. #3243372

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2024/859 of 18 March 2024 amending Regulation (EU) No 37/2010 as regards the classification of the substance sodium salicylate with respect to its maximum residue limit in foodstuffs of animal origin

  20. #3243434

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2024/860 of 18 March 2024 amending Regulation (EU) No 37/2010 as regards the substance 17ß-oestradiol

  21. #3244532

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2024/875 of 21 March 2024 adopting a list of abbreviations and pictograms common throughout the Union to be used on the packaging of veterinary medicinal products for the purposes of Article 10(2) and Article 11(3) of Regulation (EU) 2019/6 of the European Parliament and of the Council

  22. #3244656

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2024/878 of 21 March 2024 adopting uniform rules on the size of small immediate packaging units of veterinary medicinal products as referred to in Article 12 of Regulation (EU) 2019/6 of the European Parliament and of the Council

  23. #3250018

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    Commission Implementing Regulation (EU) 2024/916 of 26 March 2024 amending Implementing Regulation (EU) 2021/17 establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council

  24. #2074994

    Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir le tuairim an Bhuanchoiste um Plandaí, Ainmhithe, Bia agus Beatha, an Bhuanchoiste um Tháirgí Íocshláinte Tréidliachta agus an Bhuanchoiste ar Zóiteicnic,

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, the Standing Committee on Veterinary Medicinal Products and the Standing Committee on Zootechnics,

    Commission Implementing Regulation (EU) 2021/963 of 10 June 2021 laying down rules for the application of Regulations (EU) 2016/429, (EU) 2016/1012 and (EU) 2019/6 of the European Parliament and of the Council with regard to the identification and registration of equine animals and establishing model identification documents for those animals (Text with EEA relevance)

  25. #2147572

    I gcomhréir le tuairimí tromlaigh ó na Ballstáit arna gcur in iúl ag cruinniú an Bhuanchoiste um Tháirgí Íocshláinte Tréidliachta an 2 Nollaig 2019, agus le comhairliúchán spriocdhírithe le geallsealbhóirí tríd an ríomhphost an 26 Samhain 2019, ba cheart an lógó coiteann a mhúnlú ar an lógó coibhéiseach le haghaidh táirgí íocshláinte lena n-úsáid ag an duine.

    In accordance with the majority opinions of the Member States expressed at the Standing Committee on Veterinary Medicinal Products’ meeting of 2 December 2019, and a targeted consultation of stakeholders by email on 26 November 2019, the common logo should be modelled on the equivalent logo for medicinal products for human use.

    Commission Implementing Regulation (EU) 2021/1904 of 29 October 2021 adopting the design of a common logo for the retail of veterinary medicinal products at a distance (Text with EEA relevance)